LIGAND PHARMACEUTICALS INCORPORATED Other Investments
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Other Investments of $114.48 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:OtherInvestments · last filed 2026-08-07
- 2026-06-30: Other Investments $114.48M.
- 2026-03-31: Other Investments $87.77M.
- 2025-12-31: Other Investments $121.45M.
- 2025-09-30: Other Investments $106.72M.
| Period end | Other Investments | Other Investments as first filed |
|---|---|---|
| 2026-06-30 | $114.48M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $87.77M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $121.45M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $106.72M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $10.91M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $10.91M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $10.91M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $10.91M 10-K · filed 2025-02-28 | $11.91M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $10.74M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $36.50M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $36.73M 10-K · filed 2025-02-28 | $35.73M 10-K · filed 2024-02-29 |
| 2022-12-31 | $3.00M 10-K · filed 2024-02-29 |